Rau et al. found that the DOT1L inhibitors SYC-52221 and EPZ004777 decreased tumor cell proliferation and induced cell apoptosis, cycle arrest and terminal differentiation in DNMT3A mutant cell lines in a dose- and time-dependent manner (62). The gene discussed is DNMT3A; the disease is neoplasm.